172 related articles for article (PubMed ID: 14581472)
21. Survivin regulates the p53 tumor suppressor gene family.
Wang Z; Fukuda S; Pelus LM
Oncogene; 2004 Oct; 23(49):8146-53. PubMed ID: 15361831
[TBL] [Abstract][Full Text] [Related]
22. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
Wall NR; O'Connor DS; Plescia J; Pommier Y; Altieri DC
Cancer Res; 2003 Jan; 63(1):230-5. PubMed ID: 12517802
[TBL] [Abstract][Full Text] [Related]
23. Suppression of Polo like kinase 1 (PLK1) by p21(Waf1) mediates the p53-dependent prevention of caspase-independent mitotic death.
Lin YC; Sun SH; Wang FF
Cell Signal; 2011 Nov; 23(11):1816-23. PubMed ID: 21726628
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of histone deacetylases by chlamydocin induces apoptosis and proteasome-mediated degradation of survivin.
De Schepper S; Bruwiere H; Verhulst T; Steller U; Andries L; Wouters W; Janicot M; Arts J; Van Heusden J
J Pharmacol Exp Ther; 2003 Feb; 304(2):881-8. PubMed ID: 12538846
[TBL] [Abstract][Full Text] [Related]
25. Regulation of survivin function by Hsp90.
Fortugno P; Beltrami E; Plescia J; Fontana J; Pradhan D; Marchisio PC; Sessa WC; Altieri DC
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13791-6. PubMed ID: 14614132
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
Kappler M; Bache M; Bartel F; Kotzsch M; Panian M; Würl P; Blümke K; Schmidt H; Meye A; Taubert H
Cancer Gene Ther; 2004 Mar; 11(3):186-93. PubMed ID: 14739938
[TBL] [Abstract][Full Text] [Related]
27. Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis.
Connell CM; Wheatley SP; McNeish IA
Cancer Res; 2008 Oct; 68(19):7923-31. PubMed ID: 18829549
[TBL] [Abstract][Full Text] [Related]
28. [Research advances on inhibitor of apoptosis, survivin].
Yang J; Liu FX; Yan XC
Ai Zheng; 2003 Jul; 22(7):771-4. PubMed ID: 12866973
[TBL] [Abstract][Full Text] [Related]
29. The cyclin-dependent kinase inhibitor p21(CIP1/WAF1) blocks paclitaxel-induced G2M arrest and attenuates mitochondrial injury and apoptosis in p53-null human leukemia cells.
Ahmed W; Rahmani M; Dent P; Grant S
Cell Cycle; 2004 Oct; 3(10):1305-11. PubMed ID: 15467449
[TBL] [Abstract][Full Text] [Related]
30. Caspase 2-mediated tumor suppression involves survivin gene silencing.
Guha M; Xia F; Raskett CM; Altieri DC
Oncogene; 2010 Mar; 29(9):1280-92. PubMed ID: 19935698
[TBL] [Abstract][Full Text] [Related]
31. Survivin modulates microtubule dynamics and nucleation throughout the cell cycle.
Rosa J; Canovas P; Islam A; Altieri DC; Doxsey SJ
Mol Biol Cell; 2006 Mar; 17(3):1483-93. PubMed ID: 16407408
[TBL] [Abstract][Full Text] [Related]
32. A p34(cdc2) survival checkpoint in cancer.
O'Connor DS; Wall NR; Porter AC; Altieri DC
Cancer Cell; 2002 Jul; 2(1):43-54. PubMed ID: 12150824
[TBL] [Abstract][Full Text] [Related]
33. Distinct dynamics of Aurora B and Survivin during mitosis.
Delacour-Larose M; Molla A; Skoufias DA; Margolis RL; Dimitrov S
Cell Cycle; 2004 Nov; 3(11):1418-26. PubMed ID: 15483398
[TBL] [Abstract][Full Text] [Related]
34. p53 deficiency and defective mitotic checkpoint in proliferating T lymphocytes increase chromosomal instability through aberrant exit from mitotic arrest.
Baek KH; Shin HJ; Yoo JK; Cho JH; Choi YH; Sung YC; McKeon F; Lee CW
J Leukoc Biol; 2003 Jun; 73(6):850-61. PubMed ID: 12773518
[TBL] [Abstract][Full Text] [Related]
35. Curcumin affects components of the chromosomal passenger complex and induces mitotic catastrophe in apoptosis-resistant Bcr-Abl-expressing cells.
Wolanin K; Magalska A; Mosieniak G; Klinger R; McKenna S; Vejda S; Sikora E; Piwocka K
Mol Cancer Res; 2006 Jul; 4(7):457-69. PubMed ID: 16849521
[TBL] [Abstract][Full Text] [Related]
36. Regulation of microtubule stability and mitotic progression by survivin.
Giodini A; Kallio MJ; Wall NR; Gorbsky GJ; Tognin S; Marchisio PC; Symons M; Altieri DC
Cancer Res; 2002 May; 62(9):2462-7. PubMed ID: 11980633
[TBL] [Abstract][Full Text] [Related]
37. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
Tomicic MT; Christmann M; Kaina B
J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
[TBL] [Abstract][Full Text] [Related]
38. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Li F; Zhu Y; Woods WG; Findley HW
J Pharmacol Exp Ther; 2002 Oct; 303(1):124-31. PubMed ID: 12235242
[TBL] [Abstract][Full Text] [Related]
39. Significant impact of survivin on myeloma cell growth.
Romagnoli M; Trichet V; David C; Clément M; Moreau P; Bataille R; Barillé-Nion S
Leukemia; 2007 May; 21(5):1070-8. PubMed ID: 17315024
[TBL] [Abstract][Full Text] [Related]
40. Localization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell.
Temme A; Rieger M; Reber F; Lindemann D; Weigle B; Diestelkoetter-Bachert P; Ehninger G; Tatsuka M; Terada Y; Rieber EP
Mol Biol Cell; 2003 Jan; 14(1):78-92. PubMed ID: 12529428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
